Replies to post #8022 on Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

That's really a non-issue. Because if they get a positive signal in the human trial, this share price is going to sky rocket and they will be immediately approached by Big Pharma for a bidding war buyout. That's what the CEO said he's hoping for. Big Pharma would take over and ramp up production.

[Money $hot]

I agree with what you said here:

Flyer

Upon successful clinical trials the demand would be huge and immediate.

You're thinking of demand as in manufacturing and selling a drug. I'm thinking of demand as in Big Pharma demanding a licensing deal or acquisition/buyout. Algernon is not going to get in the business of selling drugs. Algernon is a buyout target. So, what I'm doing is "compressing" my focus on exactly how Algernon achieves it's stated goal (Licensing and/or Acquisition). We have waited approximately 18 months for this time to come - "First Patient Dosing." This is the 10th trading day before a human clinical trial begins.

Today is the official start of the countdown to launch.



The overall market doesn't understand the significance of the South Korea clinical trial.

Just 1 opinion,

/////AMG

$AGNPF

[shell3]

#MidasLetter - This will help you and Midas puts 6 Months from Interview

Your question lies within this Video and remember that now going into Humans in Sourh Korea and also a study with FDA in Animals to see if new intravenous is safe for Humans

The FDA has advised that for the toxicology program of the new intravenous Ifenprodil formulation, a single animal 30-day study would be acceptable.

Question there is — Is the Pill already approved ??

Good Video and before any approvals that I listed above

Mars Uniform Still Fits